Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Tax Rate (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Tax Rate for 12 consecutive years, with 225.13% as the latest value for Q3 2025.

  • On a quarterly basis, Tax Rate rose 25145.0% to 225.13% in Q3 2025 year-over-year; TTM through Sep 2025 was 37.86%, a 5342.0% increase, with the full-year FY2024 number at 26.46%, down 2094.0% from a year prior.
  • Tax Rate was 225.13% for Q3 2025 at Theravance Biopharma, up from 25.13% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 225.13% in Q3 2025 to a low of 73.7% in Q4 2024.
  • A 5-year average of 7.64% and a median of 0.0% in 2022 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: tumbled -1389bps in 2024, then soared 25145bps in 2025.
  • Theravance Biopharma's Tax Rate stood at 0.01% in 2021, then tumbled by -121bps to 0.0% in 2022, then plummeted by -687582bps to 18.03% in 2023, then plummeted by -309bps to 73.7% in 2024, then soared by 405bps to 225.13% in 2025.
  • Per Business Quant, the three most recent readings for TBPH's Tax Rate are 225.13% (Q3 2025), 25.13% (Q2 2025), and 4.24% (Q1 2025).